DELPHINUS MEDICAL TECHNOLOGIES
Delphinus Medical Technologies develops, commercializes, sells, and services the breast cancer screening solutions to hospitals and imaging clinics in the United States and internationally. It commercializes SoftVue, a three-dimensional and tomographic ultrasound imaging and risk assessment device that examines women's breasts for the presence of benign and/or malignant masses, assesses breast cancer risks, diagnoses breast diseases, and monitors therapy. The company was founded in 2009 and is based in Detroit, Michigan.
DELPHINUS MEDICAL TECHNOLOGIES
Industry:
Biotechnology Health Care Medical Medical Device
Founded:
2010-01-01
Address:
Novi, Michigan, United States
Country:
United States
Website Url:
http://www.delphinusmt.com
Total Employee:
11+
Status:
Active
Contact:
734-233-3088
Total Funding:
66.73 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Google Universal Analytics Font Awesome
Similar Organizations
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Current Advisors List
Current Employees Featured
Founder
Investors List
North Coast Technology Investors
North Coast Technology Investors investment in Series C - Delphinus Medical Technologies
Arboretum Ventures
Arboretum Ventures investment in Series C - Delphinus Medical Technologies
Beringea
Beringea investment in Series C - Delphinus Medical Technologies
Hopen Life Science Ventures
Hopen Life Science Ventures investment in Series C - Delphinus Medical Technologies
Waycross Ventures
Waycross Ventures investment in Series C - Delphinus Medical Technologies
Venture Investors
Venture Investors investment in Series C - Delphinus Medical Technologies
North Coast Technology Investors
North Coast Technology Investors investment in Series B - Delphinus Medical Technologies
Beringea
Beringea investment in Series B - Delphinus Medical Technologies
Arboretum Ventures
Arboretum Ventures investment in Series B - Delphinus Medical Technologies
Beringea
Beringea investment in Series A - Delphinus Medical Technologies
Official Site Inspections
http://www.delphinusmt.com Semrush global rank: 5.53 M Semrush visits lastest month: 1.54 K
- Host name: 20.51.235.207
- IP address: 20.51.235.207
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago